New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
September 25, 2012
08:10 EDTSVASinovac Biotech awarded tenders for Hep A vaccine
Sinovac Biotech announced that it has been selected by the Beijing Health Bureau and the Shanghai Centers for Disease Control and Prevention to supply the company's inactivated hepatitis A vaccine, Healive, to the Expanded Program of Immunization for each city. The tenders awarded to Sinovac in Beijing and Shanghai are valued at approximately RMB20M and RMB13M, respectively.
News For SVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 4, 2016
06:15 EDTSVASinovac announces receipt of competing non-binding 'going private' proposal
Subscribe for More Information
February 1, 2016
06:16 EDTSVASinovac Biotech receives preliminary non-binding acquisition proposal
Subscribe for More Information
January 28, 2016
06:15 EDTSVASinovac Biotech announces issuance of GMP certificate for EV71 vaccine
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use